A patient-derived missense mouse model of Kabuki syndrome 1
Disease Models & Mechanisms · 2026
DOI: 10.1242/dmm.052775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Sara Tholl Halldorsdottir und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Louma G. Laboratory of Epigenetic Research, Faculty of Medicine, University of Iceland, Reykjavik 102, Iceland. Hauptthemen laut MEDLINE: Vestibular Diseases, Abnormalities, Multiple, Face, Hematologic Diseases. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RannÃ-s, Rannais, Louma Private G. Foundation.
Abstract (Originalsprache)
Kabuki syndrome type 1 (KS1) is a rare cause of intellectual disability resulting from heterozygous pathogenic variants in the gene encoding the histone methyltransferase KMT2D. A previously established loss-of-function mouse model of KS1 exhibits key phenotypic features, and therapeutic trials in this mouse model suggest postnatal malleability of neurological symptoms. However, 15-30% of individuals with KS1 carry missense variants. To investigate whether missense variants lead to similar phenotypic presentation in mice, we used CRISPR-Cas9 to introduce the KS1 patient variant R5179H, corresponding to R5230H in mice, into C57BL/6NTac animals. Computational and in vitro testing suggested that the R5230H variant does not impair protein stability or enzyme function of KMT2D. Despite a distinct mechanistic basis, our new mouse model (Kmt2d+/R5230H) recapitulated most phenotypes of our prior loss-of-function model, including growth deficiency, craniofacial anomalies and IgA deficiency, but not altered neurological function. Kmt2d+/R5230H mice showed perinatal lethality and a high frequency of unilateral kidney agenesis, a novel phenotype in KS1 mouse models. Kmt2d+/R5230H mice provide a unique opportunity to understand the impact of missense variants on KMT2D function and uncover developmental and perinatal abnormalities in KS1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Louma G. Laboratory of Epigenetic Research, Faculty of Medicine, University of Iceland, Reykjavik 102, Iceland.
- Department of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavik 101, Iceland.
- McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Pediatrics, Johns Hopkins University, Baltimore, MD 21205, USA.
ORCID-Profile: Sara Tholl Halldorsdottir, Meghna Vinod, Ellen Dagmar Bjornsdottir, Romain Maurice Jacques Lasseur, Teresa Luperchio, Jill A Fahrner, Agnes Ulfig, Hans Tomas Bjornsson
Förderung
- RannÃ-s
- Rannais
- Louma Private G. Foundation
- BeHeard Project
- Rannís
- Innviðasjóður
- Háskóli Íslands
Zitieren
APA
Halldorsdottir, S. T., Vinod, M., Gunnlaugsson, H. O., Bjornsdottir, E. D., Lasseur, R. M. J., Luperchio, T., Fahrner, J. A., Ulfig, A., & Bjornsson, H. T. (2026). A patient-derived missense mouse model of Kabuki syndrome 1. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052775
Vancouver
Halldorsdottir ST, Vinod M, Gunnlaugsson HO, Bjornsdottir ED, Lasseur RMJ, Luperchio T, et al. A patient-derived missense mouse model of Kabuki syndrome 1. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052775
BibTeX
@article{Halldorsdottir2026,
author = {Halldorsdottir, Sara Tholl and Vinod, Meghna and Gunnlaugsson, Hilmar Orn and Bjornsdottir, Ellen Dagmar and Lasseur, Romain Maurice Jacques and Luperchio, Teresa and Fahrner, Jill A and Ulfig, Agnes and Bjornsson, Hans Tomas},
title = {A patient-derived missense mouse model of Kabuki syndrome 1},
journal = {Disease Models & Mechanisms},
year = {2026},
doi = {10.1242/dmm.052775}
}
EUVIMED